Cargando…
Parenteral, non-live rotavirus vaccine: recent history and future perspective
Since the widespread introduction of oral and live attenuated rotavirus vaccines around the world in 2009, the impacts of disease burden and the effects of disease reduction in developing countries have been proven. However, in low and middle-income countries, the vaccine efficacy is somewhat lower...
Autor principal: | Song, Jae Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Vaccine Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511589/ https://www.ncbi.nlm.nih.gov/pubmed/34703802 http://dx.doi.org/10.7774/cevr.2021.10.3.203 |
Ejemplares similares
-
Parenteral protein-based rotavirus vaccine
por: O’Ryan, Miguel, et al.
Publicado: (2017) -
Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine
por: Lappalainen, Suvi, et al.
Publicado: (2015) -
Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice
por: Resch, Theresa K., et al.
Publicado: (2018) -
Potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against tuberculosis: A systematic review
por: Khademi, Farzad, et al.
Publicado: (2018) -
Computed tomography recent history and future perspectives
por: Hsieh, Jiang, et al.
Publicado: (2021)